Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.818 EUR | -1.39% | -7.19% | -19.11% |
Jun. 04 | Pfizer: article on Lyme vaccine in The Lancet | CF |
Jun. 04 | Valneva: article on Lyme vaccine in The Lancet | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.11% | 586M | |
+55.55% | 59.28B | |
+43.79% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024